Related Experiment Video
Updated: Jun 5, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Thyroid cancer in Greece. A tertiary center experience
A Gkountouvas1, M Nikas, F Chatjimarkou
1Department of Endocrinology & Metabolism, Metaxa Cancer Hospital, Piraeus, Greece. gkountouvas@yahoo.com
Summary
Differentiated thyroid carcinoma (DTC) is the most common thyroid malignancy, accounting for 94% of cases. Further research is needed to understand thyroid cancer prevalence and characteristics in our country.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thyroid carcinoma encompasses a range of malignant neoplasms affecting the thyroid gland.
- Understanding the epidemiological distribution of histological subtypes is crucial for effective management and research.
Purpose of the Study:
- To determine the frequency and distribution of histological subtypes of primary thyroid carcinoma.
- To analyze the prevalence of different thyroid cancer types diagnosed at a specific department.
Main Methods:
- Retrospective analysis of patient records.
- Inclusion of all primary thyroid carcinoma cases diagnosed between January 1, 2002, and December 31, 2008.
- Categorization based on histological subtypes.
Main Results:
- Differentiated thyroid carcinoma (DTC) was the most prevalent subtype, representing 94% (1510/1607) of cases.
- Medullary thyroid carcinoma (MTC) accounted for 4% (71/1607) of cases.
- Other rare subtypes included anaplastic thyroid carcinoma (ATC), lymphomas, squamous cell carcinoma, and carcinomas of ectopic thyroid tissue, each comprising less than 1% of diagnoses.
Conclusions:
- Differentiated thyroid carcinoma is the predominant form of thyroid malignancy.
- Papillary thyroid carcinomas represent the majority of DTC cases.
- Larger-scale studies are required to elucidate the clinical characteristics, behavior, and prevalence of thyroid cancer within the country.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:21Tertiary Healthcare System
Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...